VivoSim Labs VIVS
NASDAQ VIVS
$0.17 +0.02 (+10.03%)
As of: Oct 20, 2026 · 11:53 AM EDT

VivoSim Labs (VIVS) Share-based Compensation (2011 - 2026)

Updated

VivoSim Labs' Share-based Compensation was $1.27 million in fiscal Q2 2019 (quarter ended Sep 30, 2018), down 44.6% from $2.3 million a year earlier and down 0.4% from the prior quarter.

Analysis

VivoSim Labs (VIVS) Share-based Compensation (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, VivoSim Labs' Share-based Compensation was $5.11 million through Sep 30, 2018, down 37.9% year-over-year; for FY2018 (ended Mar 31, 2018), it was $6.9 million, down 6.6% from FY2017.

  • Share-based Compensation shows a five-year compound annual growth rate of 19.4% (FY2013 to FY2018).
  • In earlier fiscal years, Share-based Compensation was $7.39 million in FY2017 (-13.6%), $8.56 million in FY2016 (+21.9%), $7.02 million in FY2015 (+52.6%) and $4.6 million in FY2014.
  • Quarterly Share-based Compensation has moved between $1.25 million (fiscal Q3 2018) and $3.1 million (fiscal Q3 2016) over five years.
  • Compared with a year earlier, Share-based Compensation has declined for four straight quarters, with an average decline of 13.6% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was fiscal Q3 2016 (growth of 95.9%); the worst was fiscal Q2 2019 (a decline of 44.6%).
  • Per Business Quant data, VIVS's Share-based Compensation in the three fiscal quarters before Q2 2019 was $1.28 million (Q1 2019), $1.3 million (Q4 2018) and $1.25 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Iqvia Holdings 44.66 Bn 36.37 Bn 1.44 Bn 95.00 Mn
2 Medpace Holdings 17.78 Bn 15.84 Bn 201.64 Mn 4.35 Mn
3 Charles River Laboratories International 15.09 Bn 14.28 Bn 363.37 Mn 19.78 Mn
4 Icon 13.80 Bn 10.92 Bn 479.29 Mn 18.46 Mn
5 Fortrea Holdings 2.22 Bn 1.59 Bn 139.20 Mn 12.60 Mn
6 Ginkgo Bioworks Holdings 633.98 Mn -128.10 Mn 18.44 Mn 7.60 Mn
7 Evotec SE 525.63 Mn -1.09 Bn - -
8 Champions Oncology 66.64 Mn 41.72 Mn 7.70 Mn 766,000.00
9 MindWalk Holdings 60.76 Mn 24.41 Mn 1.61 Mn 530,728.82
10 VivoSim Labs 914,286.14 -16.81 Mn - 91,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 91,000.00
Mar 31, 2026 86,000.00
Dec 31, 2025 67,000.00
Sep 30, 2025 72,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 91,000.00
Dec 31, 2024 130,000.00
Sep 30, 2024 155,000.00
Jun 30, 2024 156,000.00
Mar 31, 2024 201,000.00
Dec 31, 2023 157,000.00
Sep 30, 2023 675,000.00
Jun 30, 2023 475,000.00
Mar 31, 2023 500,000.00
Dec 31, 2022 544,000.00
Sep 30, 2022 673,000.00
Jun 30, 2022 660,000.00
Mar 31, 2022 827,000.00
Dec 31, 2021 588,000.00
Sep 30, 2021 426,000.00
API Access

VivoSim Labs Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VIVS&period=max&api_key=YOUR_API_KEY